CERRITO MARIA GRAZIA

Ruolo: 
Tecnico - amministrativo
Telefono: 
0264488339
Stanza: 
U8, Piano: IV, Stanza: L4.6B
Via Cadore, 48 - 20900 MONZA

Pubblicazioni

  • Sala, L., Cirillo, G., Riva, G., Romano, G., Giussani, C., Cialdella, A., et al. (2019). Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype. FRONTIERS IN MOLECULAR NEUROSCIENCE, 12. Dettaglio
  • Giordano, F., Vaira, V., Cortinovis, D., Bonomo, S., Goedmakers, J., Brena, F., et al. (2019). p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 38(1). Dettaglio
  • Basile, D., Gerratana, L., Buonadonna, A., Garattini, S., Perin, T., Grassilli, E., et al. (2019). Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer. CANCERS, 11(6). Dettaglio
  • Lavitrano, M., Ianzano, L., Bonomo, S., Cialdella, A., Cerrito, M., Pisano, F., et al. (2019). BTK inhibitors synergize with 5-FU to treat drug-resistant TP53-null colon cancers. JOURNAL OF PATHOLOGY. Dettaglio
  • Cerrito, M., De Giorgi, M., Pelizzoni, D., Bonomo, S., Digiacomo, N., Scagliotti, A., et al. (2018). Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. ONCOTARGET, 9(44), 27448-27459. Dettaglio